← Leaderboards
Kevin Douglas Berg
Injectsense, Inc.
$1,617,500
Attributed
$1,617,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $993.5K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,617,500 · 1
By mechanism
R44$1,617,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adverse Effects”
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$12,449,418
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
Adverse EffectsAffectAgedAdverse EventAnimal TestingBiomaterial CompatibilityBlindnessBody PositionAnimalsCeramicsChargeClinical ResearchCommercializationConjunctivaCountryCustomData CollectionData ExchangeData IntegrityData ScienceDesignDevicesEffectivenessEngineering
Grant awards (2)
iOP-Connect System for Long-Term Continuous Monitoring of Glaucoma Therapy by means of an Implantable Autonomous Intraocular Pressure Sensor$624,000
R44 · FY2023 · EY · contact PI
iOP-Connect System for Long-Term Continuous Monitoring of Glaucoma Therapy by means of an Implantable Autonomous Intraocular Pressure Sensor$993,500
R44 · FY2022 · EY · contact PI